Sanofi (Mexico) Market Value
| SNYN Stock | MXN 964.00 6.00 0.63% |
| Symbol | Sanofi |
Sanofi 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sanofi's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sanofi.
| 11/24/2024 |
| 12/24/2024 |
If you would invest 0.00 in Sanofi on November 24, 2024 and sell it all today you would earn a total of 0.00 from holding Sanofi or generate 0.0% return on investment in Sanofi over 30 days. Sanofi is related to or competes with Eli Lilly, Merck, Roche Holding, Amgen, Gilead Sciences, and Biogen. It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for muc... More
Sanofi Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sanofi's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sanofi upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 10.25 | |||
| Value At Risk | (2.89) | |||
| Potential Upside | 1.04 |
Sanofi Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sanofi's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sanofi's standard deviation. In reality, there are many statistical measures that can use Sanofi historical prices to predict the future Sanofi's volatility.| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | 0.7989 |
Sanofi Backtested Returns
Sanofi owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.15, which indicates the firm had a -0.15% return per unit of risk over the last 3 months. Sanofi exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sanofi's Variance of 1.96, risk adjusted performance of (0.10), and Coefficient Of Variation of (756.24) to confirm the risk estimate we provide. The entity has a beta of -0.24, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Sanofi are expected to decrease at a much lower rate. During the bear market, Sanofi is likely to outperform the market. At this point, Sanofi has a negative expected return of -0.22%. Please make sure to validate Sanofi's total risk alpha, potential upside, kurtosis, as well as the relationship between the treynor ratio and skewness , to decide if Sanofi performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.11 |
Insignificant reverse predictability
Sanofi has insignificant reverse predictability. Overlapping area represents the amount of predictability between Sanofi time series from 24th of November 2024 to 9th of December 2024 and 9th of December 2024 to 24th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sanofi price movement. The serial correlation of -0.11 indicates that less than 11.0% of current Sanofi price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.11 | |
| Spearman Rank Test | 0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 402.02 |
Sanofi lagged returns against current returns
Autocorrelation, which is Sanofi stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sanofi's stock expected returns. We can calculate the autocorrelation of Sanofi returns to help us make a trade decision. For example, suppose you find that Sanofi has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sanofi regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sanofi stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sanofi stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sanofi stock over time.
Current vs Lagged Prices |
| Timeline |
Sanofi Lagged Returns
When evaluating Sanofi's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sanofi stock have on its future price. Sanofi autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sanofi autocorrelation shows the relationship between Sanofi stock current value and its past values and can show if there is a momentum factor associated with investing in Sanofi.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sanofi Stock Analysis
When running Sanofi's price analysis, check to measure Sanofi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi is operating at the current time. Most of Sanofi's value examination focuses on studying past and present price action to predict the probability of Sanofi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi's price. Additionally, you may evaluate how the addition of Sanofi to your portfolios can decrease your overall portfolio volatility.